Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get your Portfolio automatically emailed to you up to 4 times a day with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Deciphera Pharmaceuticals Inc (DCPH)

Deciphera Pharmaceuticals Inc (DCPH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 2,086,896
  • Shares Outstanding, K 82,226
  • Annual Sales, $ 163,360 K
  • Annual Income, $ -194,940 K
  • 60-Month Beta 0.20
  • Price/Sales 12.78
  • Price/Cash Flow N/A
  • Price/Book 5.79
Trade DCPH with:

Options Overview Details

View History
  • Implied Volatility 12.24% ( +3.84%)
  • Historical Volatility 159.10%
  • IV Percentile 3%
  • IV Rank 2.80%
  • IV High 154.28% on 02/02/24
  • IV Low 8.15% on 05/01/24
  • Put/Call Vol Ratio 0.73
  • Today's Volume 116
  • Volume Avg (30-Day) 1,036
  • Put/Call OI Ratio 1.60
  • Today's Open Interest 12,113
  • Open Int (30-Day) 3,548

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 9 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/24
See More
  • Average Estimate -0.55
  • Number of Estimates 7
  • High Estimate -0.46
  • Low Estimate -0.63
  • Prior Year -0.60
  • Growth Rate Est. (year over year) +8.33%

Price Performance

See More
Period Period Low Period High Performance
1-Month
14.00 +81.29%
on 04/25/24
25.47 -0.35%
on 05/02/24
+10.09 (+65.99%)
since 04/03/24
3-Month
13.86 +83.12%
on 02/08/24
25.47 -0.35%
on 05/02/24
+10.90 (+75.28%)
since 02/02/24
52-Week
9.90 +156.36%
on 10/25/23
25.47 -0.35%
on 05/02/24
+11.45 (+82.20%)
since 05/03/23

Most Recent Stories

More News
Tesla, Domino's Pizza rise; AMC Entertainment, SoFi Technologies fall, Monday, 4/29/2024

Stocks that traded heavily or had substantial price changes on Monday: Tesla, Domino’s Pizza rise; AMC Entertainment, SoFi Technologies fall

FULT : 17.03 (+0.35%)
DCPH : 25.38 (unch)
UMBF : 82.56 (+0.84%)
DPZ : 514.33 (+0.32%)
Medison Pharma Announces Public Formulary Listing of QINLOCK® (ripretinib) in Canadian Provinces: Ontario and Quebec for Advanced Gastrointestinal Stromal Tumor (GIST) Treatment

/PRNewswire/ -- Today, Medison Pharma ("Medison"), a global pharma company focused on providing access to highly innovative therapies to patients in...

DCPH : 25.38 (unch)
Medison Pharma Announces Public Formulary Listing of QINLOCK® (ripretinib) in Canadian Provinces: Ontario and Quebec for Advanced Gastrointestinal Stromal Tumor (GIST) Treatment

/CNW/ -- Today, Medison Pharma ("Medison"), a global pharma company focused on providing access to highly innovative therapies to patients in international...

DCPH : 25.38 (unch)
3 Under-the-Radar Biotech Stocks to Buy in 2023

All three biotech companies focus on oncology therapies.

DCPH : 25.38 (unch)
MRTX : 58.70 (-0.17%)
MGNX : 15.67 (+2.96%)
Why Shares of Deciphera Pharmaceuticals Rose This Week

The company's shares rose after the company reported second-quarter earnings.

DCPH : 25.38 (unch)
Deciphera Pharmaceuticals to Present at the JMP Securities Life Sciences Conference

Deciphera Pharmaceuticals, Inc. (NASDAQ: DCPH), a biopharmaceutical company focused on discovering, developing, and commercializing important new medicines to improve the lives of people with cancer, today...

DCPH : 25.38 (unch)
Deciphera (DCPH) Q1 Earnings Match Estimates, Sales Miss

Deciphera Pharmaceuticals (DCPH) reports mixed first-quarter 2023 results as its earnings are in line with the Zacks Consensus Estimate, while revenues miss the same.

PFE : 27.81 (+0.40%)
ADMA : 6.81 (+1.04%)
DCPH : 25.38 (unch)
APTX : 0.0960 (+3.11%)
Deciphera Pharmaceuticals, Inc. (DCPH) Reports Q1 Loss, Lags Revenue Estimates

Deciphera Pharmaceuticals, Inc. (DCPH) delivered earnings and revenue surprises of 0% and 5.10%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?...

DCPH : 25.38 (unch)
CRIS : 16.36 (-0.91%)
Deciphera Pharmaceuticals Announces First Quarter 2023 Financial Results

Deciphera Pharmaceuticals, Inc. (NASDAQ: DCPH), a biopharmaceutical company focused on discovering, developing, and commercializing important new medicines to improve the lives of people with cancer, today...

DCPH : 25.38 (unch)
Deciphera Pharmaceuticals to Announce First Quarter 2023 Financial Results and Host Conference Call and Webcast on May 3, 2023

Deciphera Pharmaceuticals, Inc. (NASDAQ: DCPH), a biopharmaceutical company focused on discovering, developing, and commercializing important new medicines to improve the lives of people with cancer, today...

DCPH : 25.38 (unch)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is in highly overbought territory. Beware of a trend reversal.

See More Share

Business Summary

Deciphera Pharmaceuticals, Inc. develops small molecule kinase inhibitors for cancer, utilizing its proprietary kinase switch control inhibitor platform.

See More

Key Turning Points

3rd Resistance Point 25.50
2nd Resistance Point 25.47
1st Resistance Point 25.42
Last Price 25.38
1st Support Level 25.34
2nd Support Level 25.31
3rd Support Level 25.26

See More

52-Week High 25.47
Last Price 25.38
Fibonacci 61.8% 19.52
Fibonacci 50% 17.68
Fibonacci 38.2% 15.85
52-Week Low 9.90

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar